{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:54:06Z","timestamp":1793386446500,"version":"4.5.0"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1212\/con.0000000000000252","type":"journal-article","created":{"date-parts":[[2015,12,4]],"date-time":"2015-12-04T04:34:17Z","timestamp":1449203657000},"page":"1729-1744","source":"Crossref","is-referenced-by-count":37,"title":["Lyme Neuroborreliosis"],"prefix":"10.1212","volume":"21","author":[{"given":"Adriana R.","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","unstructured":"Mead PS. Epidemiology of Lyme disease. Infect Dis Clin North Am 2015; 29 (2): 187\u2013210. doi:10.1016\/j.idc.2015.02.010.","DOI":"10.1016\/j.idc.2015.02.010"},{"key":"e_1_3_1_4_2","unstructured":"Centers for Disease Control and Prevention. Reported Cases of Lyme Disease\u2014United States 2013. www.cdc.gov\/lyme\/stats\/maps\/map2013.html. Updated March 4 2015. Accessed October 6 2015."},{"key":"e_1_3_1_8_2","doi-asserted-by":"crossref","unstructured":"Nadelman RB. Erythema migrans. Infect Dis Clin North Am 2015; 29 (2): 211\u2013239. doi:10.1016\/j.idc.2015.02.001.","DOI":"10.1016\/j.idc.2015.02.001"},{"key":"e_1_3_1_14_2","doi-asserted-by":"crossref","unstructured":"Mullegger RR Glatz M. Skin manifestations of lyme borreliosis: diagnosis and management. Am J Clin Dermatol 2008; 9 (6): 355\u2013368. doi:10.2165\/0128071-200809060-00002.","DOI":"10.2165\/0128071-200809060-00002"},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","unstructured":"Halperin JJ. Nervous system Lyme disease. Infect Dis Clin North Am 2015; 29 (2): 241\u2013253. doi:10.1016\/j.idc.2015.02.002.","DOI":"10.1016\/j.idc.2015.02.002"},{"key":"e_1_3_1_16_2","doi-asserted-by":"crossref","unstructured":"Mygland A Lj\u00f8stad U Fingerle V et al.; European Federation of Neurological Societies. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 2010; 17 (1): 8\u201316 e1\u2013e4. doi:10.1111\/j.1468-1331.2009.02862.x.","DOI":"10.1111\/j.1468-1331.2009.02862.x"},{"key":"e_1_3_1_25_2","doi-asserted-by":"crossref","unstructured":"Sood SK. Lyme disease in children. Infect Dis Clin North Am 2015; 29 (2): 281\u2013294. doi:10.1016\/j.idc.2015.02.011.","DOI":"10.1016\/j.idc.2015.02.011"},{"key":"e_1_3_1_27_2","doi-asserted-by":"crossref","unstructured":"Garro AC Rutman M Simonsen K et al. Prospective validation of a clinical prediction model for Lyme meningitis in children. Pediatrics 2009; 123 (5): e829\u2013e834. doi:10.1542\/peds.2008-2048.","DOI":"10.1542\/peds.2008-2048"},{"key":"e_1_3_1_28_2","doi-asserted-by":"crossref","unstructured":"Cohn KA Thompson AD Shah SS et al. Validation of a clinical prediction rule to distinguish Lyme meningitis from aseptic meningitis. Pediatrics 2012; 129 (1): e46\u2013e53. doi:10.1542\/peds.2011-1215.","DOI":"10.1542\/peds.2011-1215"},{"key":"e_1_3_1_32_2","doi-asserted-by":"crossref","unstructured":"Marques AR. Laboratory diagnosis of Lyme disease: advances and challenges. Infect Dis Clin North Am 2015; 29 (2): 295\u2013307. doi:10.1016\/j.idc.2015.02.005.","DOI":"10.1016\/j.idc.2015.02.005"},{"key":"e_1_3_1_35_2","doi-asserted-by":"crossref","unstructured":"Ogrinc K Lotric-Furlan S Maraspin V et al. Suspected early Lyme neuroborreliosis in patients with erythema migrans. Clin Infect Dis 2013; 57 (4): 501\u2013509. doi:10.1093\/cid\/cit317.","DOI":"10.1093\/cid\/cit317"},{"key":"e_1_3_1_36_2","doi-asserted-by":"crossref","unstructured":"Djukic M Schmidt-Samoa C Lange P et al. Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis. J Neurol 2012; 259 (4): 630\u2013636. doi:10.1007\/s00415-011-6221-8.","DOI":"10.1007\/s00415-011-6221-8"},{"key":"e_1_3_1_37_2","doi-asserted-by":"crossref","unstructured":"Stanek G Lusa L Ogrinc K et al. Intrathecally produced IgG and IgM antibodies to recombinant VlsE VlsE peptide recombinant OspC and whole cell extracts in the diagnosis of Lyme neuroborreliosis. Med Microbiol Immunol 2013; 203 (2): 125\u2013132. doi:10.1007\/s00430-013-0322-1.","DOI":"10.1007\/s00430-013-0322-1"},{"key":"e_1_3_1_38_2","doi-asserted-by":"crossref","unstructured":"Henningsson AJ Christiansson M Tjernberg I et al. Laboratory diagnosis of Lyme neuroborreliosis: a comparison of three CSF anti-Borrelia antibody assays. Eur J Clin Microbiol Infect Dis 2014; 33 (5): 797\u2013803. doi:10.1007\/s10096-013-2014-6.","DOI":"10.1007\/s10096-013-2014-6"},{"key":"e_1_3_1_39_2","doi-asserted-by":"crossref","unstructured":"van Burgel ND Brandenburg A Gerritsen HJ et al. High sensitivity and specificity of the C6-peptide ELISA on cerebrospinal fluid in Lyme neuroborreliosis patients. Clin Microbiol Infect 2011; 17 (10): 1495\u20131500. doi:10.1111\/j.1469-0691.2011.03459.x.","DOI":"10.1111\/j.1469-0691.2011.03459.x"},{"key":"e_1_3_1_40_2","doi-asserted-by":"crossref","unstructured":"Cerar T Ogrinc K Lotric-Furlan S et al. Diagnostic value of cytokines and chemokines in lyme neuroborreliosis. Clin Vaccine Immunol 2013; 20 (10): 1578\u20131584. doi:10.1128\/CVI.00353-13.","DOI":"10.1128\/CVI.00353-13"},{"key":"e_1_3_1_41_2","doi-asserted-by":"crossref","unstructured":"Cerar T Ogrinc K Strle F Ruzic-Sabljic E. Humoral immune responses in patients with Lyme neuroborreliosis. Clin Vaccine Immunol 2010; 17 (4): 645\u2013650. doi:10.1128\/CVI.00341-09.","DOI":"10.1128\/CVI.00341-09"},{"key":"e_1_3_1_44_2","doi-asserted-by":"crossref","unstructured":"Coyle PK Schutzer SE Deng Z et al. Detection of Borrelia burgdorferi-specific antigen in antibody-negative cerebrospinal fluid in neurologic Lyme disease. Neurology 1995; 45 (11): 2010\u20132015. doi:10.1212\/WNL.0b013e318211c39a.","DOI":"10.1212\/WNL.45.11.2010"},{"key":"e_1_3_1_45_2","doi-asserted-by":"crossref","unstructured":"Bremell D Mattsson N Edsbagge M et al. Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection. BMC Neurol 2013; 13: 2. doi:10.1186\/1471-2377-13-2.","DOI":"10.1186\/1471-2377-13-2"},{"key":"e_1_3_1_46_2","doi-asserted-by":"crossref","unstructured":"Schmidt C Plate A Angele B et al. A prospective study on the role of CXCL13 in Lyme neuroborreliosis. Neurology 2011; 76 (12): 1051\u20131058. doi:10.1212\/WNL.0b013e318211c39a.","DOI":"10.1212\/WNL.0b013e318211c39a"},{"key":"e_1_3_1_50_2","doi-asserted-by":"crossref","unstructured":"Marques A. Chronic Lyme disease: a review. Infect Dis Clin North Am 2008; 22 (2): 341\u2013360 vii\u2013viii. doi:10.1016\/j.idc.2007.12.011.","DOI":"10.1016\/j.idc.2007.12.011"},{"key":"e_1_3_1_51_2","doi-asserted-by":"crossref","unstructured":"Feder HM Jr Johnson BJ O\u2019Connell S et al. A critical appraisal of \u201cchronic Lyme disease\u201d. N Engl J Med 2007; 357 (14): 1422\u20131430. doi:10.1056\/NEJMra072023.","DOI":"10.1056\/NEJMra072023"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1212\/CON.0000000000000252","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:10:48Z","timestamp":1752156648000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/CON.0000000000000252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["10.1212\/CON.0000000000000252"],"URL":"https:\/\/doi.org\/10.1212\/con.0000000000000252","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]}}}